Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROTEOME SCIENCES PLC Director's Dealing 2014

Jul 8, 2014

7860_dirs_2014-07-08_55fdd6f4-018b-46ca-a6b6-3eaa36ae2af4.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7876L

Proteome Sciences PLC

08 July 2014

PRESS RELEASE

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Director's Shareholding

The Company has been informed that Roger McDowell, Non-Executive Director, today purchased 500,000 ordinary shares of 1p each a price of 37.474 pence per share. Following this transaction, Mr. McDowell holds in 500,000 ordinary shares in Proteome Sciences, representing approximately 0.23 per cent. of the Company's issued share capital.

- Ends -

For further information please contact:

Proteome Sciences plc
Christopher Pearce, Executive Chairman Tel: +44 (0)1932 865065
Dr. Ian Pike, Chief Operating Officer

James Malthouse, Finance Director
Nominated Adviser
Cenkos
Stephen Keys/Callum Davidson Tel: +44 (0)20 7397 8900
Public Relations
IKON Associates
Adrian Shaw
Tel: +44 (0)1483 271291

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSSSEFMAFLSELW